Bright-Line Policy and the Future of the Fourteen-Day Rule

IF 2.3 3区哲学 Q1 ETHICS

Hastings Center Report Pub Date : 2025-10-15 DOI:10.1002/hast.70018

Anna C. Mastroianni, Jeffrey P. Kahn

引用次数: 0

Abstract

As global science leaders revisit the fourteen-day rule for human embryo research, this commentary explores why its clarity, stability, and the public trust it has fostered have made it a notable success in science policy—and why any change must be approached with care.

Abstract Image

查看原文本刊更多论文

光明路线政策和14天规则的未来。

当全球科学领袖重新审视人类胚胎研究的14天规则时，这篇评论探讨了为什么它的明确性、稳定性和它所培养的公众信任使它成为科学政策中一个显著的成功，以及为什么任何改变都必须谨慎对待。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Hastings Center Report 医学-卫生保健

CiteScore

3.50

自引率

3.00%

发文量

审稿时长

6-12 weeks

期刊介绍： The Hastings Center Report explores ethical, legal, and social issues in medicine, health care, public health, and the life sciences. Six issues per year offer articles, essays, case studies of bioethical problems, columns on law and policy, caregivers’ stories, peer-reviewed scholarly articles, and book reviews. Authors come from an assortment of professions and academic disciplines and express a range of perspectives and political opinions. The Report’s readership includes physicians, nurses, scholars, administrators, social workers, health lawyers, and others.